Gabapentin and Omacor drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Gabapentin (gabapentin) and Omacor (omega-3acid ethyl esters). Common drug interactions include diarrhoea among females and chronic obstructive pulmonary disease among males.
The phase IV clinical study analyzes what interactions people have when they take Gabapentin and Omacor. It is created by eHealthMe based on reports of 69 people who take the same drugs from the FDA, and is updated regularly.
What is Gabapentin?
Gabapentin has active ingredients of gabapentin. It is often used in peripheral neuropathy. eHealthMe is studying from 322,990 Gabapentin users. Check the latest studies of Gabapentin.
What is Omacor?
Omacor has active ingredients of omega-3acid ethyl esters. It is often used in high blood cholesterol. eHealthMe is studying from 2,547 Omacor users. Check the latest studies of Omacor.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
69 people who take Gabapentin and Omacor together, and have interactions are studied.

What are the common drug interactions of Gabapentin and Omacor, by gender? *:
female:
- Diarrhoea
- Dizziness
- Flatulence (flatus expelled through the anus)
- Hyperkalaemia (damage to or disease of the kidney)
- International normalised ratio increased
- Intervertebral disc protrusion (spinal disc protrusion)
- Organ failure
- Overdose
- Spinal fracture (fracture in one of vertebrae)
- Abdominal pain upper
male:
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Fatigue (feeling of tiredness)
- Muscle spasms (muscle contraction)
- Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
- Pancreatitis (inflammation of pancreas)
- Pancreatitis acute (sudden inflammation of pancreas)
- Prostate cancer
- Skin fissures (a crack in the skin)
- Surgery
- Thyroid disorder (thyroid diseases)
What are the common drug interactions of Gabapentin and Omacor, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Basophil count increased
- Blood creatine phosphokinase increased
- Malaise (a feeling of general discomfort or uneasiness)
- Mean cell haemoglobin concentration decreased (less concentration of haemoglobin in a given volume of packed red blood cells)
- Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
- Platelet count increased
- Red cell distribution width increased
- Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
- Viral infection
- Eosinophilia (eosinophil count in the peripheral blood exceeds)
40-49:
- Abscess limb (limb infection)
- Cellulitis (infection under the skin)
- Cellulitis of male external genital organ (infection of male genitals soft tissue)
- Colon gangrene (colon tissue dies)
- Deformity (disfigurement)
- Infected dermal cyst
- Nerve injury
- Perineal abscess
- Perirectal abscess
- Rectal abscess (pus in rectum)
50-59:
- Eosinophil count increased
- Eosinophilia (eosinophil count in the peripheral blood exceeds)
- Eosinophilic pneumonia (eosinophil accumulates in the lung)
- Erectile dysfunction
- Haematuria (presence of blood in urine)
- Hypersensitivity
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Intracranial pressure increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid)
- Loss of consciousness
- Loss of libido (loss of sexual urge)
60+:
- Bowel movement irregularity
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Dry skin
- Fatigue (feeling of tiredness)
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Post procedural haemorrhage (post procedural bleeding)
- Alopecia (absence of hair from areas of the body)
- Blood calcium decreased
- Blood phosphorus decreased
- Coagulation time prolonged
What are the existing conditions these people have? *
- High Blood Pressure: 11 people, 15.94%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 14.49%
- Back Pain: 9 people, 13.04%
- Pain: 9 people, 13.04%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 11.59%
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 7 people, 10.14%
- Nausea (feeling of having an urge to vomit): 6 people, 8.70%
- Multiple Myeloma (cancer of the plasma cells): 5 people, 7.25%
- Type 2 Diabetes: 5 people, 7.25%
- Infection: 5 people, 7.25%
* Approximation only. Some reports may have incomplete information.
Do you take Gabapentin and Omacor?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Gabapentin (322,990 reports)
- Omacor (2,547 reports)
Browse all drug interactions of Gabapentin and Omacor:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Gabapentin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Omacor:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Gabapentin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Omacor and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on gabapentin and omega-3acid ethyl esters (the active ingredients of Gabapentin and Omacor, respectively), and Gabapentin and Omacor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Gabapentin and Omacor - 3 seconds ago
- Could Dostinex cause Neck Pain? - 10 seconds ago
- Could Coreg cause Scan Myocardial Perfusion Abnormal? - 15 seconds ago
- Could Lantus cause Asthma Aggravated? - 23 seconds ago
- Could Aprepitant cause Muscle Aches? - 26 seconds ago
- Could Famotidine cause Systemic Sclerosis (Scleroderma)? - 31 seconds ago
- Could Vitamin D cause Laryngospasm? - 33 seconds ago
- Could Donepezil Hydrochloride cause Gastric Ulcer Haemorrhage? - 41 seconds ago
- Could Multihance cause Abdominal Pain Upper? - 47 seconds ago
- Could Pepcid Ac cause Upper Respiratory Tract Infection? - 47 seconds ago